PharmaBio concluded an agreement with Nagoya City University to conduct a “clinical trial on human (autologous) iris pigment epithelial (IPE) cell sheet transplantation for myopic chorioretinal atrophy”.
For inquiries regarding this matter, please contact the following.
Manager, Pharmaceutical Promotion Department：Seiji Shibata
TEL: 03-6205-4101
FAX: 03-6205-4102
E-mail：ir_admin@pharmabio.co.jp
HP：https://www.pharmabio.co.jp/